PCRX Pacira BioSciences, Inc. - Common Stock

NASDAQ · Pharmaceuticals · Wyświetl na SEC EDGAR ↗
$22,50
Cena · Maj 20, 2026
Dane fundamentalne na dzień Kwi 30, 2026

PCRX Migawka akcji Cena, kapitalizacja rynkowa, P/E, EPS, ROE, zadłużenie/kapitał własny, zakres 52-tygodniowy

Cena
$22.50
Kapitalizacja Rynkowa
$1.06B
P/E (TTM)
161.8
EPS (TTM)
$0.16
Przychody (TTM)
$726M
Stopa dywidendy
ROE
0.97%
D/E Dług/Kapitał
0.5
Zakres 52 tyg.
$19 – $28

PCRX Wykres ceny akcji Dzienny OHLCV ze wskaźnikami technicznymi — przesuwaj, powiększaj i dostosowuj widok

Wyniki 10-letnie Trendy przychodów, zysku netto, marż i EPS

Przychody i Zysk Netto $726M
10-point trend, +162.8%
2016-12-31 2025-12-31
EPS $0.16
10-point trend, +115.7%
2016-12-31 2025-12-31
Wolny przepływ pieniężny $137M
10-point trend, +1462.9%
2016-12-31 2025-12-31
Marże 0.97%

Wycena Wskaźniki P/E, P/S, P/B, EV/EBITDA — czy akcje są drogie, czy tanie?

Wskaźnik
Trend 5-letni
PCRX
Mediana porównawcza
P/E (TTM)
5-point trend, +147.3%
161.8
42.1
P/S (TTM)
5-point trend, -70.5%
1.5
11.8
P/B
5-point trend, -58.3%
1.5
3.4
EV / EBITDA
2-point trend, +118.0%
10.9
Price / FCF (Cena / FCF)
5-point trend, -76.9%
7.8

Rentowność Marże brutto, operacyjne i netto; ROE, ROA, ROIC

Wskaźnik
Trend 5-letni
PCRX
Mediana porównawcza
Operating Margin (Marża Operacyjna)
5-point trend, -75.5%
2.6%
Net Profit Margin (Marża Zysku Netto)
5-point trend, -97.1%
0.97%
-5.7%
ROA
5-point trend, -80.1%
0.50%
-5.4%
ROE
5-point trend, -83.2%
0.97%
-23.4%
ROIC
5-point trend, -91.8%
0.75%

Zdrowie finansowe Dług, płynność, wypłacalność — siła bilansu

Wskaźnik
Trend 5-letni
PCRX
Mediana porównawcza
Debt / Equity (Dług / Kapitał Własny)
2-point trend, -0.8%
0.5
Current Ratio (Wskaźnik bieżący)
5-point trend, +173.4%
4.5
4.0
Quick Ratio (Wskaźnik Szybkości)
5-point trend, +108.1%
3.0

Rozwój Wzrost przychodów, EPS i zysku netto: r/r, CAGR 3-letni, CAGR 5-letni

Wskaźnik
Trend 5-letni
PCRX
Mediana porównawcza
Revenue YoY (Przychody R/R)
5-point trend, +34.1%
3.6%
Revenue CAGR 3Y (Przychody CAGR 3L)
5-point trend, +34.1%
2.9%
Revenue CAGR 5Y (Przychody CAGR 5L)
5-point trend, +34.1%
11.1%
EPS YoY
5-point trend, -82.6%
161.8%
Net Income YoY (Zysk Netto R/R)
5-point trend, -83.2%
163.7%

Wskaźniki na akcję EPS, wartość księgowa na akcję, przepływy pieniężne na akcję, dywidenda na akcję

Wskaźnik
Trend 5-letni
PCRX
Mediana porównawcza
EPS (Diluted) (EPS (Rozwodniony))
5-point trend, -82.6%
$0.16

Efektywność kapitałowa Rotacja aktywów, rotacja zapasów, rotacja należności

Wskaźnik
Trend 5-letni
PCRX
Mediana porównawcza

PCRX Konsensus analityków Bycze i niedźwiedzie opinie analityków, 12-miesięczny cel cenowy, potencjał wzrostu

KUP 13 analityków
  • Mocne kupno 3 23,1%
  • Kup 6 46,2%
  • Trzymaj 3 23,1%
  • Sprzedaj 1 7,7%
  • Mocna sprzedaż 0 0,0%

12-miesięczny cel cenowy

7 analityków · 2026-05-14
Średni cel $27.00 +20,0%
Średnia cel $29.29 +30,2%

Historia zysków EPS faktyczny vs szacowany, zaskoczenie %, wskaźnik trafień, data następnych wyników

Średnie zaskoczenie
-0.05%
Okres EPS Actual EPS Szacowany Niespodzianka
31 marca 2026 $0.60 $0.57 0.03%
31 grudnia 2025 $0.57 $0.92 -0.35%
30 września 2025 $0.70 $0.66 0.04%
30 czerwca 2025 $0.74 $0.72 0.02%
31 marca 2025 $0.62 $0.61 0.01%

Porównanie jednostek Kluczowe metryki w porównaniu do konkurentów z sektora

Ticker Kapitalizacja Rynkowa P/E Przychody r/r Marża Netto ROE Marża brutto
PCRX $1.06B 161.8 3.6% 0.97% 0.97%
LXRX $421M -8.2 60.2% -101.1% -39.7%
ETON $457M 104.9% -5.8% -18.4% 53.5%
PHAT $1.18B -5.5 216.9% -126.4% 52.4% 87.1%
OMER $1.23B -343.6 1.9%
ESPR -33.6 21.3% -5.6% 6.2%
AMPH $1.22B 13.2 -1.7% 13.6% 12.7% 49.5%
LBRX $563M -7.1 -25.5%
RLMD $354M -3.3 93.7% -112.0%

Pełne podstawowe wskaźniki Wszystkie wskaźniki roczne — rachunek zysków i strat, bilans, przepływy pieniężne

Rachunek zysków i strat 17
Dane roczne Rachunek zysków i strat dla PCRX
Wskaźnik Trend 202520242023202220212020201920182017201620152014
Revenue 12-point trend, +267.5% $726M $701M $675M $667M $542M $430M $421M $337M $287M $276M $249M $198M
Cost of Revenue 12-point trend, +93.4% $150M $170M $185M $199M $140M $117M $107M $87M $88M $110M $72M $77M
R&D Expense 12-point trend, +526.3% $117M $82M $76M $85M $56M $59M $72M $56M $57M $46M $29M $19M
SG&A Expense 12-point trend, +245.7% $369M $294M $269M $255M $199M $194M $201M $177M $161M $153M $139M $107M
Operating Expenses 12-point trend, +248.7% $707M $774M $587M $607M $452M $383M $411M $321M $312M $308M $240M $203M
Operating Income 12-point trend, +471.6% $19M $-73M $88M $60M $90M $46M $10M $16M $-25M $-32M $9M $-5M
Interest Expense 10-point trend, +145.3% · · $20M $40M $32M $26M $24M $22M $18M $7M $8M $8M
Interest Income 12-point trend, +5850.8% $23M $20M $11M $5M $896.0K $5M $7M $6M $4M $1M $678.0K $382.0K
Other Non-op 12-point trend, -4063.5% $-7M $-373.0K $-186.0K $-11M $-3M $3M $-5M $-888.0K $167.0K $-82.0K $-165.0K $-159.0K
Pretax Income 12-point trend, +224.6% $17M $-63M $62M $13M $56M $20M $-11M $-425.0K $-42M $-38M $2M $-14M
Income Tax 12-point trend, +5587.9% $10M $36M $20M $-3M $14M $-125M $268.0K $46.0K $140.0K $105.0K $264.0K $173.0K
Net Income 12-point trend, +151.3% $7M $-100M $42M $16M $42M $146M $-11M $-471.0K $-43M $-38M $2M $-14M
EPS (Basic) 12-point trend, +141.0% $0.16 $-2.15 $0.91 $0.35 $0.95 $3.41 $-0.27 $-0.01 $-1.07 $-1.02 $0.05 $-0.39
EPS (Diluted) 12-point trend, +141.0% $0.16 $-2.15 $0.89 $0.34 $0.92 $3.33 $-0.27 $-0.01 $-1.07 $-1.02 $0.04 $-0.39
Shares (Basic) 12-point trend, +26.3% 44,566,000 46,245,000 46,222,000 45,521,000 44,262,000 42,671,000 41,513,000 40,911,000 39,806,000 37,236,000 36,540,000 35,299,000
Shares (Diluted) 12-point trend, +27.6% 45,042,000 46,245,000 51,979,000 46,538,000 45,630,000 43,682,000 41,513,000 40,911,000 39,806,000 37,236,000 41,301,000 35,299,000
EBITDA 12-point trend, +2163.1% $110M $5M $163M $152M $118M $66M $30M $29M $-11M $-19M $21M $5M
Bilans 30
Dane roczne Bilans dla PCRX
Wskaźnik Trend 202520242023202220212020201920182017201620152014
Cash & Equivalents 12-point trend, +322.6% $159M $277M $153M $104M $586M $100M $78M $133M $54M $36M $54M $38M
Short-term Investments 12-point trend, -33.0% $80M $208M $125M $185M $71M $422M $214M $251M $257M $137M $102M $119M
Receivables 12-point trend, +454.7% $124M $113M $106M $98M $96M $53M $48M $38M $32M $30M $26M $22M
Inventory 12-point trend, +422.4% $153M $125M $104M $96M $99M $65M $58M $49M $41M $31M $62M $29M
Prepaid Expense 12-point trend, +631.2% $33M $22M $22M $15M $15M $12M $11M $8M $7M $9M $6M $4M
Current Assets 12-point trend, +155.8% $548M $745M $510M $498M $866M $652M $409M $478M $391M $243M $253M $214M
PP&E (Net) 12-point trend, +132.0% $141M $167M $174M $184M $188M $137M $105M $109M $107M $101M $90M $61M
PP&E (Gross) 12-point trend, +244.8% $278M $300M $309M $301M $274M $215M $180M $170M $156M $139M $115M $81M
Accum. Depreciation 12-point trend, +584.6% $138M $133M $135M $117M $85M $78M $75M $62M $49M $38M $25M $20M
Goodwill 12-point trend, -14.9% $20M $0 $163M $163M $145M $100M $100M $62M $55M $47M $31M $24M
Intangibles 11-point trend, +91240.0% $368M $426M $483M $541M $624M $97M $104M $0 · $0 $81.0K $403.0K
Other Non-current Assets 5-point trend, -74.6% · · · · · · · $657.0K $825.0K $624.0K $406.0K $3M
Total Assets 12-point trend, +287.9% $1.26B $1.55B $1.57B $1.68B $2.08B $1.27B $831M $689M $628M $391M $388M $326M
Accounts Payable 12-point trend, +124.2% $15M $19M $16M $15M $11M $10M $13M $14M $15M $8M $9M $7M
Accrued Liabilities 12-point trend, +237.7% $96M $80M $64M $90M $128M $71M $70M $46M $41M $37M $35M $28M
Current Liabilities 12-point trend, -13.9% $121M $310M $97M $148M $521M $253M $108M $61M $56M $45M $150M $140M
Capital Leases 8-point trend, +36176000.00 $36M $45M $55M $65M $72M $71M $41M $0 · · · ·
Deferred Tax 2-point trend, +4213000.00 $4M $0 · · · · · · · · · ·
Other Non-current Liabilities 12-point trend, +280.3% $21M $17M $14M $10M $20M $4M $2M $17M $16M $19M $11M $5M
Total Liabilities 12-point trend, +269.1% $572M $775M $704M $906M $1.34B $655M $476M $368M $349M $172M $169M $155M
Long-term Debt 7-point trend, +261.0% $372M $585M $522M $689M · · · · · $109M $104M $103M
Total Debt 4-point trend, +210.2% $372M · · · · · · · · $119M $119M $120M
Common Stock 12-point trend, +33.3% $48.0K $47.0K $46.0K $46.0K $45.0K $44.0K $42.0K $41.0K $41.0K $37.0K $37.0K $36.0K
Paid-in Capital 12-point trend, +121.2% $1.06B $1.01B $977M $924M $942M $873M $754M $710M $669M $565M $527M $481M
Retained Earnings 12-point trend, +35.7% $-199M $-206M $-107M $-149M $-212M $-254M $-399M $-388M $-389M $-346M $-308M $-310M
Treasury Stock 3-point trend, +176565000.00 $177M $25M $0 · · · · · · · · ·
AOCI 12-point trend, +5508.8% $4M $343.0K $247.0K $-380.0K $167.0K $318.0K $322.0K $-280.0K $-454.0K $-30.0K $-52.0K $-80.0K
Stockholders' Equity 12-point trend, +305.0% $693M $778M $870M $775M $730M $620M $355M $321M $279M $219M $218M $171M
Liabilities + Equity 12-point trend, +287.9% $1.26B $1.55B $1.57B $1.68B $2.08B $1.27B $831M $689M $628M $391M $388M $326M
Shares Outstanding 12-point trend, +13.7% 41,116,739 47,078,000 46,481,000 45,928,000 44,734,000 43,637,000 41,908,148 41,222,799 40,668,877 37,480,952 36,848,319 36,150,620
Przepływy pieniężne 18
Dane roczne Przepływy pieniężne dla PCRX
Wskaźnik Trend 202520242023202220212020201920182017201620152014
D&A 12-point trend, +807.1% $91M $79M $76M $92M $29M $20M $20M $13M $14M $13M $11M $10M
Stock-based Comp 12-point trend, +131.7% $58M $51M $48M $48M $42M $40M $34M $32M $32M $31M $33M $25M
Deferred Tax 9-point trend, +6477000.00 $6M $21M $16M $-8M $11M $-127M $-2M $0 $0 · · ·
Amort. of Intangibles 12-point trend, +7061.0% $57M $57M $57M $57M $14M $8M $6M $0 $0 $100.0K $300.0K $800.0K
Restructuring 8-point trend, +134.9% $4M $9M $1M $0 $0 $-38.0K $847.0K $2M · · · ·
Other Non-cash 12-point trend, -332.0% $-10M $138M $-26M $-2M $2M $-2M $30M $4M $15M $27M $-18M $4M
Operating Cash Flow 12-point trend, +472.2% $152M $189M $155M $145M $126M $77M $71M $49M $18M $33M $28M $27M
CapEx 12-point trend, -33.3% $15M $11M $15M $30M $46M $38M $10M $15M $19M $25M $40M $23M
Investing Cash Flow 9-point trend, +144.5% $99M $-83M $78M $-225M $-21M $-278M $-128M $21M $-224M · · ·
Debt Issued 3-point trend, -4000.00 · · · · · · · · · $-4.0K $-1M $0
Net Debt Issued 2-point trend, +99.7% · · · · · · · · · $-4.0K $-1M ·
Stock Repurchased 4-point trend, +148328000.00 $148M $25M $0 $0 · · · · · · · ·
Net Stock Activity 2-point trend, -493.3% $-148M $-25M · · · · · · · · · ·
Financing Cash Flow 9-point trend, -264.9% $-370M $17M $-183M $-402M $381M $222M $4M $9M $224M · · ·
Net Change in Cash 8-point trend, -250.8% $-118M $123M $49M $-481M $486M $22M $-54M $78M · · · ·
Taxes Paid 3-point trend, +104.8% $9M $11M $4M · · · · · · · · ·
Free Cash Flow 12-point trend, +3717.3% $137M $179M $139M $115M $80M $39M $60M $34M $-1M $9M $-12M $4M
Levered FCF 10-point trend, +2716.3% · · $126M $67M $56M $-147M $36M $10M $-20M $2M $-19M $-5M
Rentowność 7
Dane roczne Rentowność dla PCRX
Wskaźnik Trend 202520242023202220212020201920182017201620152014
Operating Margin 11-point trend, +201.1% 2.6% · 13.0% 9.0% 16.6% 10.8% 2.5% 4.7% -8.7% -11.6% 3.8% -2.6%
Net Margin 11-point trend, +114.0% 0.97% · 6.2% 2.4% 7.8% 33.9% -2.6% -0.14% -14.9% -13.7% 0.75% -6.9%
Pretax Margin 11-point trend, +133.9% 2.3% · 9.1% 2.0% 10.4% 4.7% -2.5% -0.13% -14.8% -13.7% 0.85% -6.9%
EBITDA Margin 11-point trend, +516.7% 15.2% · 24.2% 22.7% 21.9% 15.4% 7.1% 8.6% -3.9% -6.9% 8.4% 2.5%
ROA 12-point trend, +109.0% 0.50% -6.4% 2.6% 0.85% 2.5% 13.8% -1.5% -0.07% -8.4% -9.7% 0.52% -5.5%
ROE 12-point trend, +107.5% 0.97% -13.0% 4.9% 2.1% 5.8% 24.2% -3.1% -0.15% -17.1% -17.3% 0.95% -12.9%
ROIC 12-point trend, +141.7% 0.75% -14.9% 6.9% 9.3% 9.2% 54.2% 3.0% 5.5% -8.9% -9.5% 2.5% -1.8%
Płynność i wypłacalność 5
Dane roczne Płynność i wypłacalność dla PCRX
Wskaźnik Trend 202520242023202220212020201920182017201620152014
Current Ratio 12-point trend, +196.9% 4.5 2.4 5.2 3.4 1.7 2.6 3.8 7.9 7.0 5.4 1.7 1.5
Quick Ratio 12-point trend, +135.1% 3.0 1.9 3.9 2.6 1.4 2.3 3.2 6.9 6.1 4.5 1.2 1.3
Debt / Equity 4-point trend, -23.4% 0.5 · · · · · · · · 0.5 0.5 0.7
LT Debt / Equity 0.5 · · · · · · · · · · ·
Interest Coverage 10-point trend, +792.1% · · 4.3 1.5 2.8 1.8 0.4 0.7 -1.4 -4.5 1.2 -0.6
Efektywność 3
Dane roczne Efektywność dla PCRX
Wskaźnik Trend 202520242023202220212020201920182017201620152014
Asset Turnover 11-point trend, -35.3% 0.5 · 0.4 0.4 0.3 0.4 0.6 0.5 0.6 0.7 0.7 0.8
Inventory Turnover 12-point trend, -68.8% 1.1 1.5 1.8 2.0 1.7 1.9 2.0 1.9 2.4 2.4 1.6 3.5
Receivables Turnover 11-point trend, -42.8% 6.1 · 6.6 6.8 7.3 8.5 9.8 9.7 9.3 9.9 10.3 10.7
Na akcję 5
Dane roczne Na akcję dla PCRX
Wskaźnik Trend 202520242023202220212020201920182017201620152014
Book Value / Share 12-point trend, +256.1% $16.86 $16.83 $18.72 $16.87 $16.33 $14.20 $8.47 $7.79 $6.87 $5.84 $5.93 $4.73
Revenue / Share 9-point trend, +167.5% $16.13 · $12.99 $14.33 $11.87 $9.84 $10.14 · $7.20 $7.42 $6.03 ·
Cash Flow / Share 10-point trend, +380.6% $3.37 $4.10 $2.98 $3.12 $2.76 $1.76 $1.70 · $0.45 $0.90 $0.70 ·
Cash / Share 12-point trend, +271.5% $3.86 $5.99 $3.30 $2.27 $13.09 $2.29 $1.87 $3.21 $1.33 $0.96 $1.55 $1.04
EPS (TTM) 12-point trend, +141.0% $0.16 $-2.15 $0.89 $0.34 $0.92 $3.33 $-0.27 $-0.01 $-1.07 $-1.02 $0.04 $-0.39
Stopy Wzrostu 9
Dane roczne Stopy Wzrostu dla PCRX
Wskaźnik Trend 202520242023202220212020201920182017201620152014
Revenue YoY 5-point trend, -86.1% 3.6% 3.9% 1.2% 23.1% 26.0% · · · · · · ·
Revenue CAGR 3Y 3-point trend, -82.2% 2.9% 9.0% 16.2% · · · · · · · · ·
Revenue CAGR 5Y 11.1% · · · · · · · · · · ·
EPS YoY 3-point trend, +323.5% · · 161.8% -63.0% -72.4% · · · · · · ·
EPS CAGR 3Y 2-point trend, +37.6% -22.2% · -35.6% · · · · · · · · ·
EPS CAGR 5Y -45.5% · · · · · · · · · · ·
Net Income YoY 3-point trend, +330.1% · · 163.7% -62.1% -71.2% · · · · · · ·
Net Income CAGR 3Y 2-point trend, +29.8% -23.8% · -33.9% · · · · · · · · ·
Net Income CAGR 5Y -45.4% · · · · · · · · · · ·
Wycena (TTM) 14
Dane roczne Wycena (TTM) dla PCRX
Wskaźnik Trend 202520242023202220212020201920182017201620152014
Revenue TTM 12-point trend, +267.5% $726M $701M $675M $667M $542M $430M $421M $337M $287M $276M $249M $198M
Net Income TTM 12-point trend, +151.3% $7M $-100M $42M $16M $42M $146M $-11M $-471.0K $-43M $-38M $2M $-14M
Market Cap 12-point trend, -66.8% $1.06B $871M $1.57B $1.77B $2.69B $2.61B $1.90B $1.77B $1.86B $1.21B $2.83B $3.21B
Enterprise Value 4-point trend, -62.2% $1.20B · · · · · · · · $1.16B $2.79B $3.17B
P/E 12-point trend, +171.2% 161.8 -8.8 37.9 113.6 65.4 18.0 -167.8 -4302.0 -42.7 -31.7 1919.8 -227.3
P/S 12-point trend, -91.0% 1.5 1.2 2.3 2.7 5.0 6.1 4.5 5.3 6.5 4.4 11.4 16.2
P/B 12-point trend, -91.8% 1.5 1.1 1.8 2.3 3.7 4.2 5.3 5.5 6.6 5.5 13.0 18.7
P / Tangible Book 5-point trend, -43.4% 3.5 2.5 7.0 24.9 · 6.2 · · · · · ·
P / Cash Flow 12-point trend, -94.4% 7.0 4.6 10.1 12.2 21.4 33.9 26.9 36.3 104.4 36.2 97.6 125.8
P / FCF 12-point trend, -99.1% 7.8 4.9 11.2 15.4 33.7 66.6 31.5 51.6 -1253.6 138.5 -230.5 895.3
EV / EBITDA 4-point trend, -98.3% 10.9 · · · · · · · · -60.5 133.3 650.6
EV / FCF 4-point trend, -99.0% 8.8 · · · · · · · · 132.3 -227.2 885.0
EV / Revenue 4-point trend, -89.7% 1.6 · · · · · · · · 4.2 11.2 16.0
Earnings Yield 12-point trend, +240.9% 0.62% -11.4% 2.6% 0.88% 1.5% 5.6% -0.60% -0.02% -2.3% -3.2% 0.05% -0.44%

Sprawozdania finansowe Rachunek zysków i strat, bilans, przepływy pieniężne — roczne, ostatnie 5 lat

Rachunek zysków i strat
2025-12-312024-12-312023-12-312022-12-312021-12-31
Przychody $726M$701M$675M$667M$542M
Marża Operacyjna % 2.6%13.0%9.0%16.6%
Zysk netto $7M$-100M$42M$16M$42M
Rozwodniony EPS $0.16$-2.15$0.89$0.34$0.92
Bilans
2025-12-312024-12-312023-12-312022-12-312021-12-31
Dług / Kapitał Własny 0.5
Wskaźnik bieżący 4.52.45.23.41.7
Wskaźnik Szybkości 3.01.93.92.61.4
Przepływy pieniężne
2025-12-312024-12-312023-12-312022-12-312021-12-31
Wolny przepływ pieniężny $137M$179M$139M$115M$80M

Moje wskaźniki Twoja osobista lista obserwowanych — wybrane wiersze z Pełnych Fundamentów

📊

Wybierz metryki, które są dla Ciebie ważne — kliknij ➕ obok dowolnego wiersza w Pełnych Fundamentach powyżej.

Twój wybór został zapisany i będzie Ci towarzyszył we wszystkich tickerach.